The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Verkes, R. J.
* Articles by Van Kempen, G. M.J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Verkes, R. J.
* Articles by Van Kempen, G. M.J.
Am J Psychiatry 155:543-547, April 1998
© 1998 American Psychiatric Association


Regular Article

Reduction by Paroxetine of Suicidal Behavior in Patients With Repeated Suicide Attempts But Not Major Depression

Robbert J. Verkes, M.D., Ph.D., Rose C. Van der Mast, M.D., Ph.D., Michiel W. Hengeveld, M.D., Ph.D., Jolien P. Tuyl, M.D., Aeilko H. Zwinderman, Ph.D., and Godfried M.J. Van Kempen, Ph.D.

OBJECTIVE: Suicidal behavior has been associated with reduced central serotonergic function. Because selective serotonin reuptake inhibitors (SSRIs) enhance serotonergic function, the authors studied the efficacy of an SSRI, paroxetine, in the prevention of recurrent suicidal behavior. METHOD: They conducted a 1-year double-blind study comparing paroxetine (40 mg/day) and placebo in 91 patients who had recently attempted suicide for at least a second time. None of the patients had experienced a major depressive episode or had any other major DSM-III-R axis I diagnoses. At least one cluster B personality disorder was present in 74 patients. RESULTS: With adjustment for the number of previous suicide attempts, paroxetine showed significant efficacy in the prevention of recurrent suicidal behavior. Among the patients who had attempted suicide fewer than five times, 12 (36%) in the placebo group (N=33) and five (17%) in the paroxetine group (N=30) made a subsequent suicide attempt. Paroxetine was also significantly more effective in patients who met fewer than 15 criteria for cluster B personality disorders than in those who met more than 15 criteria. Overall, paroxetine was not significantly different from placebo in its effect on depressive mood, hopelessness, and anger. However, the data suggest that paroxetine may have some temporary effect in reducing anger. CONCLUSIONS: This study indicates that enhancing serotonergic function with an SSRI may reduce suicidal behavior in a subgroup of patients who have attempted suicide more than once but who do not suffer from major depression.




This article has been cited by other articles:


Home page
JRSMHome page
A. Pitman
Policy on the prevention of suicidal behaviour; one treatment for all may be an unrealistic expectation
J R Soc Med, October 1, 2007; 100(10): 461 - 464.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. J. CRAWFORD, O. THOMAS, N. KHAN, and E. KULINSKAYA
Psychosocial interventions following self-harm: Systematic review of their efficacy in preventing suicide
The British Journal of Psychiatry, January 1, 2007; 190(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
A J Mitchell and M Dennis
Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff.
Emerg. Med. J., April 1, 2006; 23(4): 251 - 255.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
D. Shaffer
The Suicidal Adolescent
Focus, October 1, 2004; 2(4): 517 - 523.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
P. Tyrer and A. W. Bateman
Drug treatment for personality disorders
Advan. Psychiatr. Treat., September 1, 2004; 10(5): 389 - 398.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. N. Gaynes, S. L. West, C. A. Ford, P. Frame, J. Klein, and K. N. Lohr
Screening for Suicide Risk in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, May 18, 2004; 140(10): 822 - 835.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. M. Anderson, R. A. Richell, and C. M. Bradshaw
The effect of acute tryptophan depletion on probabilistic choice
J Psychopharmacol, January 1, 2003; 17(1): 3 - 7.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
D. OWENS, J. HORROCKS, and A. HOUSE
Fatal and non-fatal repetition of self-harm: Systematic review
The British Journal of Psychiatry, September 1, 2002; 181(3): 193 - 199.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. Isacsson and C. L Rich
Regular review: Management of patients who deliberately harm themselves
BMJ, January 27, 2001; 322(7280): 213 - 215.
[Full Text]


Home page
Evid. Based Ment. HealthHome page
P. S Links
Review: a lack of evidence exists to indicate the most effective treatment for patients who have deliberately harmed themselves
Evid. Based Ment. Health, May 1, 1999; 2(2): 46 - 46.
[Full Text]


Home page
Am. J. PsychiatryHome page
A. C. Leon, M. B. Keller, M. G. Warshaw, T. I. Mueller, D. A. Solomon, W. Coryell, and J. Endicott
Prospective Study of Fluoxetine Treatment and Suicidal Behavior in Affectively Ill Subjects
Am J Psychiatry, February 1, 1999; 156(2): 195 - 201.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org